Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells
Keywords: LAM; lymphangioleiomyomatosis; LOH; loss of heterozygosity; TPN; total parenteral nutrition; TSC; tuberous sclerosis complex; VEGF-D; vascular endothelial growth factor D;